Pyxis Oncology (PYXS) Ownership - Who owns Pyxis Oncology?
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PYXS showed earnings on May 15, 2025. You can read more about the earnings report here.